Cantex Pharmaceuticals and Headlamp Health are teaming up to fast-track an oral treatment for the debilitating depression and fatigue that affects many people living with multiple sclerosis (MS). The partnership centers…
Discussion
I have a bad habit. OK, several, but I’m only going to address one of them today. I tend to have a lot of imaginary debates or arguments in my head where I anticipate another person’s points, counterpoints, and questions to craft a perfect response. It isn’t an entirely bad…
Discussion
In stable relapsing-remitting multiple sclerosis (RRMS), higher physical disability scores and brain volume loss on MRI are stronger indicators of cognitive impairment than common blood biomarkers. A new study found that while blood tests often fail to reflect mental decline, MRI scans and standard disability tests can successfully identify…
Discussion
28bio has developed miniature brain models to help evaluate potential treatments that aim to repair myelin, the fatty coating around nerve fibers that is damaged in multiple sclerosis (MS) and other conditions. The CNS-3D Myelinated Organoids contain multiple brain cell types, including nerve cells and myelin-producing oligodendrocytes.
Discussion
Two commonly used disease-modifying treatments seem to be equally effective for most people with late-onset multiple sclerosis (LOMS), according to a real-world analysis. Anti-CD20 therapies, designed to reduce immune cells that produce disease-driving antibodies, and S1P receptor modulators, which work by preventing pro-inflammatory immune cells from reaching the brain,…
Get regular updates to your inbox.
